The Joint Corp.

JYNT Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.4%, EPS grew 400.0% and free cash flow grew 432.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

7.03 0.12 +1.74%
Market cap
$97.7M
P/E
26.0×
Fwd P/E
16.9×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
32.52 38.48 45.89 0.00

+8 more quarters

P/S ratio
2.14 2.22 2.40 2.69
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
57.05 (85.02) 45.55 82.57
P/B ratio
7.88 8.10 8.75 6.44
Price to Tangible BV
10.75 11.15 12.17 7.92
EV/Sales
1.78 1.87 2.00 2.16
EV/EBITDA
33.11 44.79 137.04 120.11
EV/Operating CF
19.32 26.11 59.66 38.32
EV/FCF
(99.45) (40.51) (22.20) (32.31)
Quick Ratio
1.06 0.79 0.83 1.02
Current Ratio
1.83 1.64 1.59 1.83
Net Debt/EBITDA
(411.51) (16.76) (20.50) (49.22)
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.94 0.82 0.76 0.73
Operating CF/Net income
3.36 (1.14) 2.92 2.07
Capex/Depreciation
(0.60) (0.58) (0.79) (0.69)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
81.96% 72.89% 73.65% 75.57%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
2.79% 1.89% 2.15% 2.59%
Graham Net Nets
0.06 0.06 0.05 0.09
Graham Number
2.60 2.38 2.06 0.00
Earnings Yield
3.08% 2.60% 2.18% (0.63%)
Free Cash Flow Yield
(0.84%) (2.09%) (3.74%) (2.49%)
Revenue per Share
1.07 1.05 1.00 0.87
Operating CF per Share
0.15 (0.10) 0.19 0.12
Capex per Share
(0.02) (0.02) (0.02) (0.02)
Free Cash Flow per Share
0.14 (0.12) 0.17 0.09
Cash per Share
1.61 1.51 1.61 2.00
Shareholders Equity per Share
1.11 1.09 1.00 1.48
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.11 1.09 1.00 1.48
Free Cash Flow
1.94 (1.71) 2.55 1.46
Working Capital
19.82 19.42 19.27 27.45
Capital Expenditures
(0.26) (0.23) (0.35) (0.32)
Net Current Asset Value
8.05 7.16 6.20 13.84
EV/EBIT
73.91 166.08 0.00 0.00
Capex to Sales
0.02 0.02 0.02 0.02
Price to Operating Income
88.81 196.47 0.00 0.00
Other line items
Average Receivables
2.60 2.66 2.72 3.60
Average Payables
1.34 0.99 1.67 1.55
Average Assets
62.41 69.01 72.06 74.49
Average Common Equity
19.57 19.17 17.88 21.60

Fold the line items

Columns are period end dates